Craft

Advanced
  • Home
  •  / Harmony Biosciences
Harmony Biosciences

Harmony Biosciences

Stock Price

$41.5

2024-10-29

Market Capitalization

$2.4 B

2024-10-29

Revenue

$714.7 M

FY, 2024

Harmony Biosciences Summary

Company Summary

Overview
Harmony Biosciences develops therapies to help patients with unmet medical needs. The Company provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders.
Type
Public
Status
Active
Founded
2017
HQ
Plymouth Meeting, PA, US | view all locations
Website
https://www.harmonybiosciences.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • John C. Jacobs

    John C. Jacobs, President and Chief Executive Officer

  • Juan Sabater, Director

    • Gary Sender, Director

      • Linda Szyper, Director

        LocationsView all

        1 location detected

        • Plymouth Meeting, PA HQ

          United States

          630 W Germantown Pike #220

        Harmony Biosciences Financials

        Summary Financials

        Revenue (Q1, 2025)
        $184.7M
        Gross profit (Q1, 2025)
        $152.7M
        Net income (Q1, 2025)
        $45.6M
        Cash (Q1, 2025)
        $489.0M
        EBIT (Q1, 2025)
        $56.2M
        Enterprise value
        $2.1B

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2025
        Share price data provided by IEX